These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, Nakhoul N, Hoffman A, Abassi Z. Am J Physiol Renal Physiol; 2008 Mar; 294(3):F628-37. PubMed ID: 18094029 [Abstract] [Full Text] [Related]
26. Difficult-to-treat nephrotic syndrome: management and outcome. Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S. J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434 [Abstract] [Full Text] [Related]
27. Tolerability of enalapril in mild to moderate hypertension. Sharma S, Gupta U, Bapna JS, Sahai A. J Assoc Physicians India; 1995 Jul; 43(7):475-6. PubMed ID: 8713222 [No Abstract] [Full Text] [Related]
29. Severe chemosis in a patient with nephrotic syndrome. Jankauskiene A, Buteikiene I. Eur J Pediatr; 2009 Apr 17; 168(4):507-8. PubMed ID: 18661147 [Abstract] [Full Text] [Related]
33. ACE-inhibitors-induced metabolic acidosis in a child with nephrotic syndrome. Bruno I, Pennesi M, Marchetti F. Pediatr Nephrol; 2003 Dec 17; 18(12):1293-4. PubMed ID: 14579142 [Abstract] [Full Text] [Related]
35. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome. Liern M, Colazo A, Vallejo G, Zotta E. Nefrologia (Engl Ed); 2021 Dec 17; 41(3):304-310. PubMed ID: 36166246 [Abstract] [Full Text] [Related]
36. Failure to treat heart failure. Lancet; 1992 Feb 01; 339(8788):278-9. PubMed ID: 1346289 [No Abstract] [Full Text] [Related]